Open Orphan has released its H1 2021 results. The numbers represent a milestone for the Group, delivering both positive EBITDA and bottom line profits in its half year for the first time. While H2 looks slightly uneven, this remains a rapidly growing business in a market increasingly well understood by investors and with significant opportunity for high returns in 2022 and beyond, there remains lots to go for. Reiterate Buy.
20 Sep 2021
Open Orphan* - Industry Momentum Accelerating Pipeline Conversion
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Open Orphan* - Industry Momentum Accelerating Pipeline Conversion
hVIVO plc (HVO:LON) | 28.0 0.1 1.8% | Mkt Cap: 190.5m
- Published:
20 Sep 2021 -
Author:
Andrew Simms | Philip Modu -
Pages:
7
Open Orphan has released its H1 2021 results. The numbers represent a milestone for the Group, delivering both positive EBITDA and bottom line profits in its half year for the first time. While H2 looks slightly uneven, this remains a rapidly growing business in a market increasingly well understood by investors and with significant opportunity for high returns in 2022 and beyond, there remains lots to go for. Reiterate Buy.